Preferred Research Partners, Inc. — research payments reported

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$20,441	5
2024	Research	$30,469	4
2019	Research	$112,608	12

Breakdown

Who paid Research payments · program years 2019–2025

AbbVie, Inc. $88,886 9 payments
Idorsia Pharmaceuticals US Inc $50,910 9 payments
Vanda Pharmaceuticals Inc. $23,722 3 payments

Studies the money was for Research payments · program years 2019–2025

M16-100 $88,886 9 payments
Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Polysomnography, Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Multiple-dose Oral Administration of Daridorexant in Pediatric Subjects Aged 10 to < 18 Years With Insomnia Disorder $50,910 9 payments
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis $23,722 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.